| RS1553551493 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Developmental and epileptic encephalopathy 6B |
| RS1553551498 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553551595 |
NEB
|
Health Risk |
Pathogenic |
— |
| RS1553551647 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1553551650 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553551651 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553551705 |
SATB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Chromosome 2q32-q33 deletion syndrome |
| RS1553551748 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553551874 |
DIS3L2
|
Health Risk |
Likely pathogenic |
Nephroblastoma, Nephroblastoma |
| RS1553552310 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553552319 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553552378 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1553552384 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553552390 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553552413 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553553086 |
FARSB
|
Health Risk |
Pathogenic |
Cirrhosis of liver, Cerebral calcification |
| RS1553553248 |
COL6A3
|
Health Risk |
Likely pathogenic |
— |
| RS1553553267 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1553553313 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1553553327 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS1553553462 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553553485 |
SCN1A
|
Health Risk |
Pathogenic |
Febrile seizure (within the age range of 3 months to 6 years), Febrile seizure (within the age range of 3 months to 6 years) |
| RS1553553527 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553553593 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553553614 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553553625 |
COL6A3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Bethlem myopathy 1A |
| RS1553553646 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1553553671 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553553888 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS1553553943 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS1553554007 |
TRNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS1553554298 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1553554384 |
COL6A3
|
Health Risk |
Pathogenic |
— |
| RS1553554543 |
FARSB
|
Health Risk |
Pathogenic |
Cirrhosis of liver, Cerebral calcification |
| RS1553555585 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS1553555768 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553555882 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1553555919 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553556116 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy |
| RS1553556154 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553556275 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553557405 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553557696 |
COL6A3
|
Health Risk |
Likely pathogenic |
— |
| RS1553558398 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553560676 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553560677 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Early-infantile DEE |
| RS1553560710 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553560740 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553560760 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553560766 |
SCN1A
|
Health Risk |
Likely pathogenic |
Sudden unexplained death in childhood, Sudden unexplained death in childhood |
| RS1553560785 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553560831 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1553560951 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553561016 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553561023 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553561211 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553561409 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1553561525 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553561665 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553561697 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553562022 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553562490 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553562753 |
TTN
|
Health Risk |
Likely pathogenic |
Primary familial dilated cardiomyopathy, Dilated cardiomyopathy 1G |
| RS1553562793 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553563398 |
ERBB4
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553563519 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553564078 |
ATP2B2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1553564139 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553564141 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553564144 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553564213 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1553564400 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Complex neurodevelopmental disorder |
| RS1553564589 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553564693 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553564694 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553565140 |
TWIST2
|
Health Risk |
Pathogenic |
Ablepharon macrostomia syndrome, Inborn genetic diseases |
| RS1553565143 |
TWIST2
|
Health Risk |
Pathogenic |
Barber-Say syndrome, Barber-Say syndrome |
| RS1553565278 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553565316 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS1553565463 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1553566820 |
ECEL1
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis type 5D, Distal arthrogryposis type 5D |
| RS1553567130 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1553567304 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS1553567347 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1553567381 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553567409 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial infantile |
| RS1553567411 |
ECEL1
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis type 5D, Distal arthrogryposis type 5D |
| RS1553567473 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553567561 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1553567622 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553567864 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Epilepsy |
| RS1553567936 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1553567937 |
ECEL1
|
Health Risk |
Pathogenic |
Distal arthrogryposis type 5D, Distal arthrogryposis type 5D |
| RS1553567991 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553568004 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553568045 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553568092 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1553568167 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553568249 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1553568357 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |